Xiaodong Gu

Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential

Adam Roberts, Xiaodong Gu, Jennifer A. Buffa et al. · Nature Medicine · 2018 · 546 citations

Medicine, Immunology, Pharmacology +14

The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study

Wenxian Wang, Xiaodong Gu, Liping Wang et al. · Cancer Immunology Immunotherapy · 2021 · 50 citations · Full text

Life Sciences, Immunology, Oncology +17

Predictors for Fear of Cancer Recurrence in Breast Cancer Patients Referred to Radiation Therapy During the COVID-19 Pandemic: A Multi-Center Cross-Section Survey

Jinrong Xie, Wei‐Xiang Qi, Lu Cao et al. · Frontiers in Oncology · 2021 · 21 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective study

Xiaodong Gu, Zhiyong Shi, Lan Shao et al. · BMC Cancer · 2022 · 11 citations · Full text

Medicine, Oncology, Pharmacotherapy +17